Schott Pharma AG KGaA's EBIT per Share for the
three
months ended in Mar. 2026 was $0.09.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.39.
During the past 12 months, the average EBIT per Share Growth Rate of Schott Pharma AG KGaA was -7.50% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 3.40% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 15.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Schott Pharma AG KGaA's EBIT per Share or its related term are showing as below:
SHTPY'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 3.4 Med: 18.1 Max: 23.1
Current: 3.4
During the past 6 years, the highest 3-Year average EBIT per Share Growth Rate of Schott Pharma AG KGaA was 23.10% per year. The lowest was 3.40% per year. And the median was 18.10% per year.
SHTPY's 3-Year EBIT Growth Rate is ranked worse than 58.55% of 690
companies
in the Medical Devices & Instruments industry
Industry Median: 9.6
vs SHTPY: 3.40
Schott Pharma AG KGaA (OTCPK:SHTPY) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Schott Pharma AG KGaA EBIT per Share Related Terms
Schott Pharma AG KGaA EBIT per Share Historical Data
* Premium members only.
The historical data trend for Schott Pharma AG KGaA's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.39
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Schott Pharma AG KGaA (SHTPY) has a EBIT per Share of $0.39 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Schott Pharma AG KGaA and its competitors. According to the industry distribution chart, Schott Pharma AG KGaA ranks #404 out of 690 companies in the Medical Devices & Instruments industry, placing it in the top 58.6%.
Is Schott Pharma AG KGaA's EBIT per Share too high?
Schott Pharma AG KGaA's current EBIT per Share is $0.39. The Medical Devices & Instruments industry median EBIT per Share is 9.60. Schott Pharma AG KGaA's value of $0.39 is 95.9% below this industry median. Based on the distribution chart, Schott Pharma AG KGaA ranks #404 out of 690 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Schott Pharma AG KGaA has a GF Score™ of 64/100, reflecting its overall financial health beyond just this single metric.
How does Schott Pharma AG KGaA's EBIT per Share compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Schott Pharma AG KGaA ranks #404 out of 690 companies for EBIT per Share. This places Schott Pharma AG KGaA in the lower half of its industry. The industry median EBIT per Share is 9.60. Schott Pharma AG KGaA's value of $0.39 is 95.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.60, based on 690 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Schott Pharma AG KGaA's current EBIT per Share of $0.39 is 95.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Schott Pharma AG KGaA and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Schott Pharma AG KGaA's current EBIT per Share is $0.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Schott Pharma AG KGaA stock overvalued right now?
Schott Pharma AG KGaA (SHTPY) has a current EBIT per Share of $0.39. The stock's GF Value™ is $7.02, compared to a current price of $4.37 — trading 37.7% below its estimated fair value. The current EBIT per Share is $0.39 and 95.9% below the Medical Devices & Instruments industry median of 9.60. Schott Pharma AG KGaA's overall GF Score™ is 64/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Schott Pharma AG KGaA (SHTPY), the current EBIT per Share is $0.39 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Schott Pharma AG KGaA (SHTPY) Overvalued in 2026?
Based on GuruFocus' analysis, Schott Pharma AG KGaA stock appears to be undervalued.
The current stock price of $4.37 is trading 37.7% below its estimated GF Value™ of $7.02.
Key valuation signals for SHTPY:
EBIT per Share: $0.39
GF Value™: $7.02 vs. price of $4.37 (37.7% below fair value)
Industry Position: 95.9% below the Medical Devices & Instruments median (#404 of 690)
No single metric tells the full story. See the SHTPY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Schott Pharma AG & CO KGaA is an international provider of drug containment solutions and delivery systems for injectable drugs for pharma, biotech and life-sciences. Its business operates in two segments: Drug Containment Solutions (DCS) and Drug Delivery Systems (DDS). The majority of revenue is being generated from the DCS segment, which includes products like vials, cartridges, and ampoules, and provides customers with sterile and non-sterile options in standard and high-end formats for drug storage. Geographically, the company generates revenue from Europe, the Middle East, Africa (EMEA), Asia and the South Pacific, North America, and South America.
64GF Score
Get the complete analysis for SHTPY
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHTPY has been successfully added to your 
